(Reuters) -The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased by an experimental non-hormonal drug being developed by Bayer, ...

While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...

DEKALB and Asgrow are rolling out 43 new corn and soybean products for 2026 featuring advanced pest and disease protection.

Bayer said it received approval in the U.K. to use elinzanetant for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes, linked with menopause.

Disclaimer: This news article is a direct feed from ANI and has not been edited by the News Nation team. The news agency is solely responsible for its content.

Women in the UK will soon have access to a new daily pill designed to alleviate hot flushes during menopause, following its ...

The New Jersey Supreme Court ordered Multicounty Litigation designation for more than 40 Roundup cases pending in New Jersey state courts.

Bayer has been hit with thousands of lawsuits alleging that Roundup’s active ingredient glyphosate causes cancer.

The U.S. Supreme Court on Monday requested the opinion of the Solicitor General in a legal dispute involving Bayer’s ( ...

The Supreme Court is seeking input from the nation's top lawyer before deciding whether to take up a petition sought by Bayer ...